Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POM121 transmembrane nucleoporin like 10, pseudogene (POM121L10P) is a non-coding pseudogene in the human genome. It shares sequence homology with the functional POM121 nucleoporin gene but does not produce a functional protein and has no known cellular activity or disease association[3][5][7][9][10]. Its designation as a pseudogene means it may have arisen from gene duplication or retrotransposition during evolution and retains partial similarity in nucleotide sequence, but it lacks the necessary coding sequence or regulatory elements for producing an active nucleoporin[6]. As such, it is not considered a receptor, enzyme, or any type of pharmacological target, and it does not interact with drugs, participate in biological functions, or serve as a biomarker[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POM121 transmembrane nucleoporin like 10, pseudogene (POM121L10P).